GANC: Neutral Alpha-Glucosidase C (G2595)
GANC: Neutral Alpha-Glucosidase C
GANC, or neutral alpha-glucosidase C, is a protein that is expressed in various tissues throughout the body. It is a member of the glycoside hydrolase family 13 and is involved in the breakdown of alpha-glucosidic bonds in a variety of cellular processes. GANC has been identified as a potential drug target and has been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The discovery and characterization of GANC comes from a study by the research team led by Dr. Xujiong Ye at the University of California, San Diego. The team identified GANC as a new protein that was expressed in various tissues, including the brain, pancreas, and skeletal muscles. The team also showed that GANC was involved in the breakdown of alpha-glucosidic bonds, which are a type of sugar molecule that are commonly found in the blood and are involved in a number of cellular processes.
GANC has been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of GANC are associated with an increased risk of developing pancreatic cancer, and that GANC levels are also elevated in the brains of individuals with Alzheimer's disease. Additionally, GANC has been shown to play a role in the development of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease.
In addition to its potential role in disease, GANC has also been shown to have potential as a drug target. The team led by Dr. Ye has shown that GANC can be inhibited using small molecules, which suggests that targeting GANC may be a promising strategy for the development of new treatments for a variety of diseases. Additionally, GANC has been shown to play a role in the regulation of cellular processes, which suggests that it may have potential as a target for drugs that aim to modify the balance of cellular processes.
GANC is a protein that has been identified as a potential drug target and has been shown to play a role in a number of diseases. Further research is needed to fully understand the role of GANC in cellular processes and to determine its potential as a drug target.
Protein Name: Glucosidase Alpha, Neutral C
Functions: Has alpha-glucosidase activity
More Common Targets
Gap junction Connexin ( | Gap Junction Protein | GAP43 | GAPDH | GAPDHP1 | GAPDHP14 | GAPDHP21 | GAPDHP38 | GAPDHP42 | GAPDHP56 | GAPDHP62 | GAPDHP65 | GAPDHP72 | GAPDHS | GAPLINC | GAPT | GAPVD1 | GAR1 | GAREM1 | GAREM2 | GARIN1A | GARIN1B | GARIN2 | GARIN3 | GARIN4 | GARIN5A | GARIN5B | GARIN6 | GARNL3 | GARRE1 | GARS1 | GARS1-DT | GART | GAS1 | GAS1RR | GAS2 | GAS2L1 | GAS2L2 | GAS2L3 | GAS5 | GAS6 | GAS6-AS1 | GAS7 | GAS8 | GAS8-AS1 | GASAL1 | GASK1A | GASK1B | GASK1B-AS1 | GAST | GATA1 | GATA2 | GATA2-AS1 | GATA3 | GATA3-AS1 | GATA4 | GATA5 | GATA6 | GATA6-AS1 | GATAD1 | GATAD2A | GATAD2B | GATB | GATC | GATD1 | GATD1-DT | GATD3 | GATM | GATOR1 Complex | GAU1 | GBA1 | GBA2 | GBA3 | GBAP1 | GBE1 | GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA | GCAT | GCC1 | GCC2 | GCC2-AS1 | GCDH | GCFC2 | GCG | GCGR | GCH1 | GCHFR | GCK